Dr. Matthew Campbell, MD
Claim this profileUT Southwestern/Simmons Cancer Center-Dallas
Studies Bladder Cancer
Studies Skin Cancer
18 reported clinical trials
35 drugs studied
Area of expertise
1Bladder Cancer
Stage III
HER2 positive
Stage IV
2Skin Cancer
Stage III
HER2 positive
Stage IV
Affiliated Hospitals
Clinical Trials Matthew Campbell, MD is currently running
Selinexor + Radiation
for Brain Cancer
This trial tests the safety and effectiveness of combining selinexor with radiation therapy in children and young adults with aggressive brain tumors. Selinexor is a drug that blocks a protein to stop cancer cells from growing. The study aims to find the best dose and see if this combination can shrink tumors.
Recruiting1 award Phase 1 & 21 criteria
Atezolizumab + Chemotherapy
for Pediatric Solid Cancers
This trial is a multi-center, non-randomized, open-label Phase I/II study evaluating the feasibility and efficacy of vincristine, irinotecan, temozolomide, and atezolizumab in children with relapsed/refractory solid tumors.
Recruiting1 award Phase 1 & 210 criteria
More about Matthew Campbell, MD
Clinical Trial Related2 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Matthew Campbell, MD has experience with
- Cyclophosphamide
- Dactinomycin
- Cisplatin
- Doxorubicin Hydrochloride
- Methotrexate
- Cabozantinib
Breakdown of trials Matthew Campbell, MD has run
Bladder Cancer
Skin Cancer
Rhabdomyosarcoma
Osteosarcoma
- A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors
- Osteosarcoma Maintenance Therapy With OST31-164
- A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Campbell, MD specialize in?
Matthew Campbell, MD focuses on Bladder Cancer and Skin Cancer. In particular, much of their work with Bladder Cancer has involved Stage III patients, or patients who are HER2 positive.
Is Matthew Campbell, MD currently recruiting for clinical trials?
Yes, Matthew Campbell, MD is currently recruiting for 7 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Matthew Campbell, MD has studied deeply?
Yes, Matthew Campbell, MD has studied treatments such as Cyclophosphamide, Dactinomycin, Cisplatin.
What is the best way to schedule an appointment with Matthew Campbell, MD?
Apply for one of the trials that Matthew Campbell, MD is conducting.
What is the office address of Matthew Campbell, MD?
The office of Matthew Campbell, MD is located at: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas 75390 United States. This is the address for their practice at the UT Southwestern/Simmons Cancer Center-Dallas.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.